soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 NEJM Editorial Fellow Harleen Marwah,

aleniglipron does not T2D data : Orforglipron has ACHIEVE-3 head-to-head vs oral semaglutide Company backing : Eli Lilly (orforglipron) vs Structure Therapeutics (aleniglipron) Conclusion# The oral GLP-1 small molecule space is developing into a two-horse race between aleniglipron and orforglipron

The 24% figure from retatrutide Phase 2, over a shorter timeframe, is meaningfully ahead of both

Recalls & Warnings September 01, 2011 Recall of Prenatal Supplement Due to Egg Allergen According to the FDA website, on August 31, 2011, Pure Encapsulations announced the voluntarily recall of it "PreNatal Nutrients" supplement, lot number 3560111, because it may contain undeclared egg allergen

Promueve la concentracin saludable de xido ntrico, lo que ayuda a mantener la presin arterial que ya se encuentra dentro de un rango saludable